Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06917339

Retrospective Analyses of TrakStar Database

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Depression Anxiety Depression Anxiety Disorders Behavior Behavioral Symptoms Mental Disorders Obsessive-Compulsive Disorder

Age range

5 year–120 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Neuronetics

Malvern, Pennsylvania, 19355, United States

Location status: Recruiting

Location contact

Eleanor Cole

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female reported in database and not an invalid entry
  • Age reported and not an invalid entry
  • Treatment date of November 01, 2008 or later.

Exclusion criteria

  • Incomplete information on treatment parameters

Treatment and study plan

NeuroStar Advanced TMS Therapy System

Device

non-invasive brain stimulation device

Primary outcomes

  1. Change in clinical assessment score from baseline to post-treatment

    Time frame: 8 weeks

    real-world efficacy of NeuroStar TMS in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9

Secondary outcomes

  1. Age at baseline and its correlation to change in score post treatment

    Time frame: 8 weeks

    Determine the patient characteristics like age that are associated with clinical outcomes- PHQ-9 following NeuroStar TMS

Study contacts

Contact information is provided by the study sponsor or research team.

Eleanor Cole, PhD

CONTACT

[email protected]

415-724-7960

Neha Goyal

CONTACT

[email protected]

763-528-1599

Sponsors and collaborators

Lead sponsor

Neuronetics

Other

Registry information

Official study title

Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes

Important dates

Study start
2025
Primary completion
2035
Study completion
2035
First posted
Apr 8, 2025
Registry last updated
Apr 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.